NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET FORECAST 2021-2028

The North America peripheral vascular devices market is projected to grow at a CAGR of 10.86% during the forecast period, 2021-2028. The increasing geriatric population and the growing number of diabetes and blood pressure patients with complications propel the market growth.

north-america-peripheral-vascular-devices-market

The North America peripheral vascular devices market growth evaluation includes the analysis of the United States and Canada. The United States benefits from a well-developed and unique healthcare system, with hospitals covered by private or government insurance. Peripheral artery disease (PAD) is a major under-treated condition in the country. It is also a prominent cause of leg amputation. Further, there are growing cases of age-related cognitive impairment due to Alzheimer’s disease, as per the American Heart Association, 2018. It contributes to the growing rate of hospitalizations, which need vascular devices-linked treatments. As per the National Institute of Health, with the increasing population, the prevalence of PAD is likely to increase.

Moreover, smoking and high blood pressure are on the rise due to the sedentary lifestyle. Also, the United States is a major country for several cardiovascular specialized companies with regard to the marketing and approval of the latest medical technologies. Such factors, along with medical reimbursement policies, are set to influence market growth in the US.

Boston Scientific Corporation develops, manufactures, and markets medical devices. The company’s products are utilized in a range of interventional medical specialties, including interventional cardiology, electrophysiology, vascular surgery, oncology, interventional radiology, etc. The company has a reliable distribution network, and invests in building a strong brand portfolio. It is headquartered in Marlborough, Massachusetts, the United States.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY                 
    1. STUDY OBJECTIVES                  
    2. SCOPE OF STUDY                      
    3. METHODOLOGY               
    4. ASSUMPTIONS & LIMITATIONS                       
  2. EXECUTIVE SUMMARY                      
    1. MARKET SIZE & ESTIMATES                
    2. MARKET OVERVIEW                  
  3. MARKET DYNAMICS
    1. KEY DRIVERS       
      1. SURGE IN DEMAND FOR MINIMALLY-INVASIVE PROCEDURES FOR PERIPHERAL ARTERIAL DISEASE          
      2. GROWING INCIDENCE OF PERIPHERAL ARTERIAL DISEASE                
      3. INCREASING AGING POPULATION AND LIFESTYLE CHANGES             
      4. TECHNOLOGICAL ADVANCEMENTS               
    2. KEY RESTRAINTS           
      1. STRINGENT REGULATIONS                   
      2. LACK OF PROPER REIMBURSEMENT POLICIES FOR PERIPHERAL VASCULAR DEVICES                     
      3. HIGH COMPETITION                      
  4. KEY ANALYTICS           
    1. IMPACT OF COVID-19 ON PERIPHERAL VASCULAR DEVICES MARKET       
    2. KEY INVESTMENT INSIGHTS               
    3. PORTER’S FIVE FORCES ANALYSIS             
      1. BUYERS POWER               
      2. SUPPLIERS POWER                     
      3. SUBSTITUTION                   
      4. NEW ENTRANTS                
      5. INDUSTRY RIVALRY                     
    4. OPPORTUNITY MATRIX             
    5. VENDOR LANDSCAPE               
  5. MARKET BY DEVICE TYPE                
    1. PERIPHERAL VASCULAR STENTS                 
      1. SELF EXPANDING PERIPHERAL VASCULAR STENTS                   
      2. BALLOON EXPANDING PERIPHERAL VASCULAR STENTS                      
      3. DRUG ELUTING PERIPHERAL VASCULAR STENTS           
      4. COVERED STENT              
    2. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS             
      1. STANDARD PTA BALLOON CATHETERS                   
      2. HIGH-PRESSURE PTA BALLOON CATHETER                       
      3. LARGE PTA BALLOON CATHETER                   
      4. SMALL PTA BALLOON CATHETER                   
      5. SPECIALTY PTA BALLOON CATHETER                      
      6. DRUG COATED PTA BALLOON CATHETER               
    3. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES        
    4. ATHERECTOMY DEVICES                    
    5. EMBOLIC PROTECTION DEVICES                 
    6. INFERIOR VENA CAVA FILTERS                     
    7. OTHER DEVICE TYPES              
  6. GEOGRAPHICAL ANALYSIS             
    1. NORTH AMERICA            
      1. KEY GROWTH ENABLERS                     
      2. KEY CHALLENGES           
      3. KEY PLAYERS                    
      4. COUNTRY ANALYSIS                   
        1. UNITED STATES                               
        2. CANADA                                                                     
  7. COMPETITIVE LANDSCAPE             
    1. KEY STRATEGIC DEVELOPMENTS               
      1. MERGERS & ACQUISITIONS                  
      2. PRODUCT LAUNCHES & DEVELOPMENTS               
      3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS   
      4. BUSINESS EXPANSIONS
    2. COMPANY PROFILES                 
      1. ABBOTT LABORATORIES           
      2. BOSTON SCIENTIFIC CORPORATION             
      3. BECTON, DICKINSON AND COMPANY            
      4. COOK GROUP                    
      5. CARDINAL HEALTH INC (CORDIS)                   
      6. EDWARDS LIFESCIENCES CORPORATION              
      7. MEDTRONIC PLC               
      8. KONINKLIJKE PHILIPS NV (VOLCANO)           
      9. ANGIOSCORE INC (SPECTRANETICS CORPORATION)                 
      10. TELEFLEX MEDICAL                  
      11. TERUMO INTERVENTIONAL SYSTEMS INC            
      12. ENDOLOGIX
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PERIPHERAL VASCULAR DEVICES

TABLE 2: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: LEADING PLAYERS OPERATING IN NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET

TABLE 11: LIST OF MERGERS & ACQUISITIONS

TABLE 12: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS

TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 14: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY INVESTMENT INSIGHTS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY DEVICE TYPE, IN 2020

FIGURE 6: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

FIGURE 7: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY PERIPHERAL VASCULAR STENTS, IN 2020

FIGURE 8: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY SELF EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY BALLOON EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG ELUTING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY COVERED STENT, 2021-2026 (IN $ MILLION)

FIGURE 12: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, IN 2020

FIGURE 14: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY STANDARD PTA BALLOON CATHETERS, 2021-2028 (IN $ MILLION)

FIGURE 15: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY HIGH-PRESSURE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY LARGE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 17: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY SMALL PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 18: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY SPECIALTY PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 19: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG COATED PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 20: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES, 2021-2028 (IN $ MILLION)

FIGURE 21: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY ATHERECTOMY DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 22: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 23: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY INFERIOR VENA CAVA FILTERS, 2021-2028 (IN $ MILLION)

FIGURE 24: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY OTHER DEVICE TYPES, 2021-2028 (IN $ MILLION)

FIGURE 25: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 26: UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 27: CANADA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample